Inventor · disambiguated record
Charles A. Flentge
Also filed as: FLENTGE CHARLES A
42 granted patents·19 pending applications·279 citations·filing 1982–2025
97Inventor score
Top patents by PatentIndex Score
61 records- 0196US11724990B2Kv7 channel activators compositions and methods of useKNOPP BIOSCIENCES LLC·Filed 2022·Granted Aug 15, 2023·4 cites·14 claims
- 0296US11261162B2KV7 channel activators compositions and methods of useKNOPP BIOSCIENCES LLC·Filed 2020·Granted Mar 1, 2022·3 cites·20 claims
- 0395US10851067B2Kv7 channel activators compositions and methods of useKNOPP BIOSCIENCES LLC·Filed 2019·Granted Dec 1, 2020·6 cites·28 claims
- 0495US9481653B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2015·Granted Nov 1, 2016·15 cites·19 claims
- 0594US8691938B2Anti-viral compoundsDEGOEY DAVID A·Filed 2010·Granted Apr 8, 2014·26 cites·2 claims
- 0693US9914708B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2016·Granted Mar 13, 2018·10 cites·16 claims
- 0792US10385025B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2018·Granted Aug 20, 2019·9 cites·16 claims
- 0892US10106536B2Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2017·Granted Oct 23, 2018·5 cites·12 claims
- 0992US8501238B2Anti-infective agents and uses thereofFLENTGE CHARLES A·Filed 2012·Granted Aug 6, 2013·21 cites·50 claims
- 1092US7517876B2Anti-infective agentsABBOTT LAB·Filed 2006·Granted Apr 14, 2009·13 cites·19 claims
- 1191US9650376B2Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2014·Granted May 16, 2017·8 cites·23 claims
- 1289US8937150B2Anti-viral compoundsDEGOEY DAVID A·Filed 2011·Granted Jan 20, 2015·11 cites·18 claims
- 1388US12351559B2Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activatorsBIOHAVEN THERAPEUTICS LTD·Filed 2023·Granted Jul 8, 2025·0 cites·16 claims
- 1485US7378414B2Anti-infective agentsABBOTT LAB·Filed 2004·Granted May 27, 2008·17 cites·30 claims
- 1585US5101015AReagents for an amphetamine-class fluorescence polarization immunoassayABBOTT LAB·Filed 1989·Granted Mar 31, 1992·53 cites·9 claims
- 1684US10906877B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2019·Granted Feb 2, 2021·1 cites·8 claims
- 1783US12286408B2KV7 channel activators compositions and methods of useBIOHAVEN THERAPEUTICS LTD·Filed 2023·Granted Apr 29, 2025·0 cites·16 claims
- 1882US9006387B2Anti-viral compoundsABBVIE INC·Filed 2014·Granted Apr 14, 2015·4 cites·9 claims
- 1978US7786153B2Compounds that are useful for improving pharmacokineticsABBOTT LAB·Filed 2006·Granted Aug 31, 2010·2 cites·28 claims
- 2078US5354693AReagents, methods and kits for an amphetamine-class fluorescence polarization immunoassyABBOTT LAB·Filed 1993·Granted Oct 11, 1994·43 cites·5 claims
- 2177US9139536B2Anti-infective agents and uses thereofABBVIE INC·Filed 2013·Granted Sep 22, 2015·2 cites·6 claims
- 2275US11834418B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsBIOHAVEN THERAPEUTICS LTD·Filed 2020·Granted Dec 5, 2023·0 cites·20 claims
- 2371US8921514B2Anti-viral compoundsDEGOEY DAVID A·Filed 2010·Granted Dec 30, 2014·1 cites·7 claims
- 2471US2025171429A1Pyrazolyl compounds as kv7 channel activatorsBIOHAVEN THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 2568US10526328B2Imidazo[4,5-b]pyridin-2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2018·Granted Jan 7, 2020·0 cites·1 claims
- 2668US2014243340A1Cytochrome p450 oxidase inhibitors and uses thereofABBVIE INC·Filed 2014·Application pending·0 cites
- 2766US2008161246A1Cytochrome P450 Oxidase Inhibitors and Uses ThereofABBOTT LAB·Filed 2007·Application pending·0 cites
- 2866US2025230152A1Pyrazolyl compounds as kv7 channel activatorsBIOHAVEN THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 2965US8741938B2Compounds that are useful for improving pharmacokineticsABBVIE INC·Filed 2013·Granted Jun 3, 2014·0 cites·20 claims
- 3064US9586978B2Anti-viral compoundsABBVIE INC·Filed 2014·Granted Mar 7, 2017·0 cites·21 claims
- 3164US2013131085A1Cytochrome p450 oxidase inhibitors and uses thereofKLEIN LARRY L·Filed 2012·Application pending·0 cites
- 3263US2012309762A1Cytochrome p450 oxidase inhibitors and uses thereofKLEIN LARRY L·Filed 2012·Application pending·0 cites
- 3363US2014194349A1HIV Protease Inhibiting CompoundsABBVIE INC·Filed 2014·Application pending·0 cites
- 3463US2025171430A1Pyrazolyl compounds as kv7 channel activatorsBIOHAVEN THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 3562US2023285378A1Anti-Viral CompoundsABBVIE INC·Filed 2022·Application pending·0 cites
- 3662US2019015402A1Anti-Viral CompoundsABBVIE INC·Filed 2018·Application pending·0 cites
- 3761US7696226B2HIV protease inhibiting compoundsABBOTT LAB·Filed 2004·Granted Apr 13, 2010·1 cites·49 claims
- 3861US2025066351A1Pyrazolo[1,5-a]pyridin-2,3-yl amides as kv7 channel activatorsBIOHAVEN THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 3961US2012083490A1Cytochrome p450 oxidase inhibitors and uses thereofKLEIN LARRY L·Filed 2011·Application pending·0 cites
- 4060US7834043B2HIV protease inhibiting compoundsABBOTT LAB·Filed 2004·Granted Nov 16, 2010·1 cites·9 claims
- 4159US10039754B2Anti-viral compoundsABBVIE INC·Filed 2017·Granted Aug 7, 2018·0 cites·17 claims
- 4259US10028937B2Anti-viral compoundsABBVIE INC·Filed 2017·Granted Jul 24, 2018·0 cites·4 claims
- 4358US9353091B2Antiviral compounds and uses thereofABBVIE INC·Filed 2014·Granted May 31, 2016·0 cites·20 claims
- 4455US7538105B2Anti-infective agentsABBOTT LAB·Filed 2008·Granted May 26, 2009·0 cites·19 claims
- 4555US4559173AN-substituted dibenz[b,f]azepine saltsABBOTT LAB·Filed 1983·Granted Dec 17, 1985·3 cites·7 claims
- 4655US4451652ASubstituted theophylline saltsABBOTT LAB·Filed 1982·Granted May 29, 1984·3 cites·5 claims
- 4754US8653141B2HIV protease inhibiting compoundsFLENTGE CHARLES A·Filed 2012·Granted Feb 18, 2014·0 cites·31 claims
- 4854US4543412APhenobarbital enzyme inhibitorsABBOTT LAB·Filed 1983·Granted Sep 24, 1985·3 cites·7 claims
- 4954US2011092415A1Anti-Viral CompoundsAbbott Labaoratories·Filed 2010·Application pending·0 cites
- 5053US8524753B2Compounds that are useful for improving pharmacokineticsKEMPF DALE J·Filed 2012·Granted Sep 3, 2013·0 cites·20 claims
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Charles A. Flentge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →